PANTHERx Rare Pharmacy Honored on Fortune's Change the World 2026 List
PANTHERx Rare Pharmacy, a leading independent pharmacy focused on rare diseases, has earned a prestigious position on the Fortune Change the World 2026 List. This list highlights companies worldwide that positively influence society through core business strategies. Selected from an array of candidates, PANTHERx is recognized in the category "Serving the Underserved," underlining its commitment to improving the lives of patients confronting rare diseases.
Commitment to Rare Disease Patients
Fortune specifically commended PANTHERx for its efforts to eliminate the various obstacles encountered by individuals with rare diseases during their treatment journeys. Patients often face clinical, financial, and administrative challenges that can obstruct access to essential medications. For countless individuals and their families, navigating the complexities of rare diseases involves not only medical uncertainty but also the difficulties of delayed diagnoses, intricate insurance stipulations, and limited access to specialized assistance.
Bansi Nagji, CEO of PANTHERx, expressed, "Living with a rare disease can feel overwhelming... Being named to the Fortune Change the World 2026 List reflects our people's unwavering commitment to improving the lives of rare disease patients." This acknowledgment is as much about the everyday dedication of PANTHERx's staff, who work closely with patients during some of their most vulnerable times, as it is about the organization’s mission.
Overcoming Barriers in Rare Disease Treatment
Statistics reveal that more than 30 million Americans battle rare diseases, with a significant number of these conditions lacking FDA-approved treatments. As novel therapies develop, the challenge remains to enable patients to not only start but also maintain their treatment regimens.
PANTHERx employs its innovative RxARECARE® operating system to assist patients through this difficult landscape. This system provides highly personalized support, expert care, and dedicated advocacy, enabling patients to navigate their treatment paths effectively and compassionately.
Evolution from a Garage Start-up
Since its founding in Pittsburgh, PA, in 2011, PANTHERx has transformed into the largest independent rare pharmacy in the United States. By combining the resources of a well-established organization with the nimbleness and innovation characteristic of smaller companies, PANTHERx has consistently delivered tailored and exceptional care. They have cultivated strong relationships with patients, prescribers, and pharmaceutical partners, positioning themselves as trusted advocates in the rare disease community.
PANTHERx is notable for its dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC), making it the first national pharmacy to achieve this distinction. Additionally, the pharmacy has been honored multiple times with the MMIT Patient Choice Award, including 2026, for its outstanding patient satisfaction.
Conclusion
Being included in the Fortune Change the World 2026 List marks an important milestone for PANTHERx Rare Pharmacy. It is a recognition of their ongoing efforts to lift the burdens facing patients suffering from rare diseases, ensuring they receive the care and support necessary for their well-being. As they look towards the future, their unwavering commitment continues to drive progress in the realm of rare disease care.
For further details about their services, visit
PANTHERx Rare Pharmacy.